Anaptysbio (ANAB) Current Leases (2020 - 2026)

Anaptysbio (ANAB) has 7 years of Current Leases data on file, last reported at $2.1 million in Q1 2026.

• Quarterly Current Leases rose 8.05% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (up 8.05% YoY) and the FY2025 annual result came in at $2.1 million, up 8.05% from the prior year.
• Current Leases advanced to $2.1 million in Q1 2026, from $2.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.1 million in Q1 2026 to a low of $1.5 million in Q1 2022.
• A 5-year average of $1.8 million and a median of $1.8 million in 2024 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2022 — Current Leases jumped 182.88% — and 2025, when it grew 8.05%.
• Tracing ANAB's Current Leases over 5 years: stood at $1.6 million in 2022, then rose by 8.55% to $1.8 million in 2023, then gained by 8.33% to $1.9 million in 2024, then climbed by 8.05% to $2.1 million in 2025, then advanced by 1.92% to $2.1 million in 2026.
• The last three Current Leases figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.